Immunowake
Birmingham
About Immunowake
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $23.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2022)
- Website: immunowake.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immunowake-13113 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.